| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/12/1997 | EP0761668A2 Non-classical antifolates |
| 03/12/1997 | EP0761661A1 Glycomimetics as selectin antagonists, and anti-inflammatory agents prepared thereof |
| 03/12/1997 | EP0761659A1 Naphthyl and dihydronaphthyl compounds as medicaments |
| 03/12/1997 | EP0760860A1 Methods of in vivo gene delivery |
| 03/12/1997 | EP0760813A1 Inhibitors of farnesyl-protein transferase |
| 03/12/1997 | EP0760685A1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 03/12/1997 | EP0760675A1 Compositions comprising dna damaging agents and p53 |
| 03/12/1997 | EP0760668A1 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 03/12/1997 | EP0760667A1 Cancer treatment and metastasis prevention |
| 03/12/1997 | EP0760660A1 Treating conditions using optically pure(-)-liarozole |
| 03/12/1997 | EP0760657A1 Novel potent inducers of terminal differentiation and methods of use thereof |
| 03/12/1997 | EP0644873B1 Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives |
| 03/12/1997 | EP0636137B1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 03/12/1997 | EP0616529B1 Drug formulations for parenteral use |
| 03/12/1997 | EP0588873B1 Treatment of liver cancer |
| 03/12/1997 | EP0565587B1 THE EFFECT OF N,N,N-TRIMETHYLSPHINGOSINE ON PROTEIN KINASE-C ACTIVITY; MELANOMA CELL GROWTH $i(IN VITRO); METASTATIC POTENTIAL $i(IN VIVO) AND HUMAN PLATELET AGGREGATION |
| 03/12/1997 | EP0489048B1 Inhibition of tumor growth by blockade of the protein c system |
| 03/12/1997 | EP0468997B1 Bacteriochlorophyll-a derivatives useful in photodynamic therapy |
| 03/12/1997 | CN1145077A Immuno-stimulatory monoclonal antibodies |
| 03/12/1997 | CN1145066A Aminostilbazole derivative and medicine |
| 03/12/1997 | CN1145032A Monoclonal anbibodies which bind to tumor rejection antigen precursor MAGE-1, recombinant MAGE-1, and MAGE-1 derived immunogenic peptides |
| 03/12/1997 | CN1145028A A improved method of synthesis for 6,9-bis|(2-aminoethyl)amino¨ benzo|g¨ isoquinoline-5,10-dione and its dimaleate salt |
| 03/12/1997 | CN1144805A Prodrugs of paclitaxel derivatives |
| 03/12/1997 | CN1144679A Medicine for treatment of multiple middle-advanced stage cancer |
| 03/12/1997 | CN1034217C Anti-proliferative and anti-inflammatory compounds:derivatives of pentose monosaccharides |
| 03/11/1997 | US5610320 Antitumor agents |
| 03/11/1997 | US5610319 Compound useful as antiproliferative agents and GARFT inhibitors |
| 03/11/1997 | US5610304 Pyrimidinyl or pyridinyl sulfonamide substituted compounds |
| 03/11/1997 | US5610280 Antitumor |
| 03/11/1997 | US5610195 Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives |
| 03/11/1997 | US5610185 Method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds |
| 03/11/1997 | US5610176 Tachykinin (NK1) receptor antagonists |
| 03/11/1997 | US5610175 9-Substituted porphycenes |
| 03/11/1997 | US5610173 Formulations for lipophilic compounds |
| 03/11/1997 | US5610166 Methods for inhibiting angiogenesis |
| 03/11/1997 | US5610150 Prostate cancer, enzyme inhibitors |
| 03/11/1997 | US5610144 Pyrrolidine and thiazolidine derivatives, their preparation and medicaments containing them |
| 03/11/1997 | US5610013 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 03/11/1997 | US5609882 Antitumor |
| 03/11/1997 | US5609867 Polymeric antitumor agents |
| 03/11/1997 | EP0699442A4 Use of a strain of the fungus fusarium as a substance producer and a preparation based onit with adaptogenic and immunomodulating properties |
| 03/09/1997 | CA2184783A1 Nonclassical antifolates |
| 03/07/1997 | CA2184881A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity prepared therefrom |
| 03/06/1997 | WO1997008334A1 Cryptophycins from aberrant biosynthesis |
| 03/06/1997 | WO1997008313A1 Variants of vascular endothelial cell growth factor, their uses, and processes for their production |
| 03/06/1997 | WO1997008310A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
| 03/06/1997 | WO1997008195A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
| 03/06/1997 | WO1997008180A1 Method to improve the biological and antiviral activity of protease inhibitors |
| 03/06/1997 | WO1997008145A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 03/06/1997 | WO1997008143A1 Inhibitors of tumor necrosis factor alpha |
| 03/06/1997 | WO1997007804A1 Combination therapy for advanced cancer comprising temozolomide and cisplatin |
| 03/06/1997 | WO1997007798A1 Pharmaceutical compounds |
| 03/06/1997 | WO1997007796A1 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 03/06/1997 | WO1997007791A1 Use of aminoadamantane compounds as immunoregulators |
| 03/06/1997 | WO1997007784A2 LIPOSOMAL PHOSPHODIESTER, PHOSPHOROTHIOATE, AND p-ETHOXY OLIGONUCLEOTIDES |
| 03/06/1997 | WO1997007769A2 Chemical compounds |
| 03/06/1997 | WO1996036354A3 Anticancer vaccine comprising il6/il6 receptor transfected cells |
| 03/06/1997 | CA2246117A1 Cryptophycins from aberrant biosynthesis |
| 03/06/1997 | CA2230689A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
| 03/06/1997 | CA2230540A1 Pharmaceutical compounds |
| 03/06/1997 | CA2230487A1 Inhibitors of tumor necrosis factor alpha |
| 03/06/1997 | CA2230209A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 03/06/1997 | CA2230144A1 Variants of vascular endothelial cell growth factor, their uses, and processes for their production |
| 03/06/1997 | CA2229141A1 Combination therapy for advanced cancer comprising temozolomide and cisplatin |
| 03/06/1997 | CA2227040A1 Chemical compounds |
| 03/05/1997 | EP0760365A2 Alkenyl-benzoylguanidines |
| 03/05/1997 | EP0760239A2 Therapeutic agents for use in cancer therapy |
| 03/05/1997 | EP0760000A1 Alphavirus expression vector |
| 03/05/1997 | EP0759992A1 Human papilloma virus inhibition by a hairpin ribozyme |
| 03/05/1997 | EP0759986A1 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein |
| 03/05/1997 | EP0759984A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors |
| 03/05/1997 | EP0759980A1 Interleukin-6 splice variant |
| 03/05/1997 | EP0759943A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 03/05/1997 | EP0759934A1 Neurotensin antagonist peptides |
| 03/05/1997 | EP0759786A1 Somatostatin binding peptide-metal chelate conjugates |
| 03/05/1997 | EP0759775A1 IFN-$g(b) LIQUID FORMULATIONS |
| 03/05/1997 | EP0759770A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 03/05/1997 | EP0759765A1 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
| 03/05/1997 | EP0759758A1 Sialic acid/fucose based medicaments |
| 03/05/1997 | EP0759757A1 Oral liquid alendronate formulations |
| 03/05/1997 | EP0759752A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 03/05/1997 | EP0759742A1 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use |
| 03/05/1997 | EP0708877B1 Method for repairing a combustion chamber assembly |
| 03/05/1997 | EP0643069B1 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof |
| 03/05/1997 | CN1144486A Treatment of ovarian estrogen dependent conditions |
| 03/05/1997 | CN1144480A Guanylhydrazones for treating inflammatory conditions |
| 03/05/1997 | CN1144114A Sanzhufuzheng anticancer oral liquor and preparation method thereof |
| 03/05/1997 | CN1144091A Compounds having retinoid-like activity |
| 03/05/1997 | CN1144089A Water-soluble gossypol preparation and its preparing method |
| 03/04/1997 | US5608082 Compounds useful as antiproliferative agents and GARFT inhibitors |
| 03/04/1997 | US5608053 Absorbers of electromagnetic radiation |
| 03/04/1997 | US5608043 Process for the preparation of 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose compounds |
| 03/04/1997 | US5608039 Single chain B3 antibody fusion proteins and their uses |
| 03/04/1997 | US5607944 Bicyclic heterocyclic compounds, pharmaceutical preparations containing these compounds and processes for their preparations |
| 03/04/1997 | US5607934 Preventing and treating diseases caused by superoxide radicals, nephritis |
| 03/04/1997 | US5607675 Treatment of autoimmune diseases with IL-2 receptor-specific cytotoxin |
| 03/02/1997 | CA2184570A1 Therapeutic agents for use in cancer therapy |
| 02/27/1997 | WO1997007214A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 02/27/1997 | WO1997007198A2 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | WO1997007134A1 Traf inhibitors |